|
|
 |
| Ad-hoc Announcement dated March 31, 2005 |
|
aap has signed today a long-term production contract with one of the global market leaders in orthopedics.
This agreement will have a significant impact on aap´s revenues and profits starting in the second half of 2005. According to current market conditions the annual revenue volume for aap during the minimum 5-year-term of the contract will exceed EUR 2 million.
aap Implantate AG is a German MedTec company, active in the fields of orthopedics, bone cement, cementing techniques and biomaterials and listed in the Prime Standard segment of the Frankfurt stock exchange. In the fiscal year 2004 the aap group of companies has achieved total sales of EUR 11.5 million.
For further information, please contact:
| aap Implantate AG | | | Lorenzweg 5 | | | D-12099 Berlin | | | X | | | Oliver Bielenstein | Nanette Hüdepohl | | Director/CFO | Investor & Public Relations | Tel.: +49 30 75019 - 140 | Tel.: +49 30 75019 - 133 | Fax: +49 30 75019 - 290 | Fax: +49 30 75019 - 290 | | X | | | WKN 506660, ISIN DE0005066609 | | | Prime Standard/Regulated Market | | | Traded at all German Stock Exchanges | |
|
|
|
|
|
Print this page
